Should Drug Manufacturers - Specialty & Generic Stock RedHill Biopharma Ltd (RDHL) Be in Your Portfolio Wednesday?

A rating of 100 puts RedHill Biopharma Ltd (RDHL) near the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. RedHill Biopharma Ltd's score of 100 means it scores higher than 100% of stocks in the industry. RedHill Biopharma Ltd also received an overall rating of 79, putting it above 79% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 140 out of the 148 industries.

RDHL has an Overall Score of 79. Find out what this means to you and get the rest of the rankings on RDHL!

See Full RDHL Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 79 would rank higher than 79 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With RedHill Biopharma Ltd Stock Today?

RedHill Biopharma Ltd (RDHL) stock is trading at $8.85 as of 12:33 PM on Wednesday, Sep 8, a loss of -$0.70, or -7.33% from the previous closing price of $9.55. The stock has traded between $8.74 and $9.47 so far today. Volume today is below average. So far 495,178 shares have traded compared to average volume of 927,536 shares. Click Here to get the full Stock Report for RedHill Biopharma Ltd stock.